Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care H.R.19, Lower Costs, More Cures Act of 2021 H.R. 5376, Build Back Better Act, including provisions related to tax CMS/NCD draft decision on monoclonal antibodies Discussions regarding coverage, coding, and reimbursement issues H.R.3/S.2543, Elijah E. Cummings Lower Drug Costs Now Act, discussions regarding support to increase Part B biosimilar payments from ASP +6% to ASP +8% of the reference product Issue regarding COVID-19, supply chain, pharmaceutical pricing and drug development lifecycle Issues related to tax reform and tax policy Tax Cuts and Jobs Act of 2017 (P.L.115-97)
HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy TAX - Taxation/Internal Revenue Code
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
JOHN RAYMOND GIBSON JONATHAN CAUSEY AMY DEMSKE AMY ABADIR DANIEL HARDER (Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018) ALI LAKHANI AMY DEMSKE AMY ABADIR TYLER HANSON JONATHAN CAUSEY DANIEL HARDER (Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018) DANIEL HARDER (Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018)
Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018 Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018 Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018